{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:59Z","timestamp":1793397959505,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013851","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000}}],"reference-count":117,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013851.pub2","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T10:45:10Z","timestamp":1685616310000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acetylcholinesterase inhibitors for autistic spectrum disorders"],"prefix":"10.1002","volume":"2023","author":[{"given":"Alexandra","family":"Ure","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Monash University; Melbourne Australia"},{"name":"Developmental Paediatrics; Monash Children's Hospital; Melbourne Australia"},{"name":"Murdoch Children's Research Institute; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina R","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Monash University; Melbourne Australia"},{"name":"Neurodevelopment and Disability; The Royal Children's Hospital; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haslam","sequence":"additional","affiliation":[{"name":"Mental Health Department; The Royal Children's Hospital; Melbourne Australia"},{"name":"Department of Paediatrics; University of Melbourne; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Monash University; Melbourne Australia"},{"name":"Developmental Paediatrics; Monash Children's Hospital; Melbourne Australia"},{"name":"Murdoch Children's Research Institute; Melbourne Australia"},{"name":"Department of Paediatrics; University of Melbourne; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0269881113508830","article-title":"Galantamine efficacy and tolerability as an augmentative therapy in autistic children: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghaleiha","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0002|cit2","unstructured":"Galantamine in the treatment of autism en.irct.ir\/trial\/890?revision=890"},{"issue":"1 - Special Iss","key":"10.1002\/14651858.CD013851.pub2-BIB0003|cit3","first-page":"125","article-title":"Safety and efficacy of donepezil in children and adolescents with autism: behavioral measures","volume":"2","author":"Handen","year":"2010","journal-title":"International Public Health Journal"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/cap.2010.0024","article-title":"Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures","volume":"21","author":"Handen","year":"2011","journal-title":"Journal of Child & Adolescent Psychopharmacology"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD013851.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"50S","DOI":"10.1016\/j.biopsych.2006.03.005","article-title":"161. Preliminary findings from a double-blind placebo-controlled study of donepezil in pervasive developmental disorders","volume":"59","author":"Hardan","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0006|cit6","unstructured":"Donepezil HCl & cognitive deficits in autism clinicaltrials.gov\/show\/NCT00047697"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/cap.2011.0056","article-title":"Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders","volume":"22","author":"Arnold","year":"2012","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-0035-1557175","article-title":"Donepezil hydrochloride: a double-blind study in autistic children","volume":"1","author":"Chez","year":"2003","journal-title":"Journal of Pediatric Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013851.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1002\/ana.1189","article-title":"Double-blinded placebo-controlled aricept study in children with autistic spectrum disorder","volume":"50","author":"Chez","year":"2001","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"224-34","DOI":"10.1007\/s12031-019-01351-7","article-title":"Improvement of language in children with autism with combined donepezil and choline treatment","volume":"69","author":"Gabis","year":"2019","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0011|cit11","unstructured":"Treatment with acetyl-choline esterase inhibitors in children with autism spectrum disorders clinicaltrials.gov\/show\/NCT01098383"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0012|cit12","unstructured":"A trial of the drug donepezil for sleep enhancement and behavioral change in children with autism clinicaltrials.gov\/ct2\/show\/NCT01887132"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"570-5","DOI":"10.1177\/0883073812449381","article-title":"Effectiveness and safety of donepezil in boys with fragile x syndrome: a double-blind, randomized, controlled pilot study","volume":"28","author":"Sahu","year":"2013","journal-title":"Journal of Child Neurology"},{"issue":"7377","key":"10.1002\/14651858.CD013851.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1136\/bmj.325.7377.1422\/a","article-title":"Galantamine may be effective in treating autistic disorder","volume":"325","author":"Niederhofer","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0015|cit15","unstructured":"The efficacy of augmentation donepezil to risperidon in treatment of autism spectrum disorders en.irct.ir\/trial\/25769"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0016|cit16","unstructured":"Galantamine versus placebo in childhood autism clinicaltrials.gov\/ct2\/show\/NCT00252603"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD013851.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"S369-70","DOI":"10.1016\/j.biopsych.2018.02.950","article-title":"S59. Alpha-7 nicotinic acetylcholine receptor positive allosteric modulator galantamine in autism spectrum disorder","volume":"83","author":"Rahman","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0018|cit18","volume-title":"Manual for the ASEBA School-Age Forms & Profiles: An Integrated System of Multi-informant Assessment","author":"Achenbach","year":"2001"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0019|cit19","volume-title":"Aberrant Behavior Checklist: Manual","author":"Aman","year":"1986"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0020|cit20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0021|cit21","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0022|cit22","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0023|cit23","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","volume":"4th, Text Revis","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0024|cit24","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1005451304303","article-title":"Assessment in multisite randomized clinical trials (RCTs) of patients with autistic disorder: the Autism RUPP Network","volume":"30","author":"Arnold","year":"2000","journal-title":"Journal of Autism and Developmental Disordorders"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"235\u20138","DOI":"10.1076\/chin.6.3.235.3152","article-title":"Behavior rating inventory of executive function","volume":"6","author":"Baron","year":"2000","journal-title":"Child Neuropsychology"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10803-012-1656-z","article-title":"Sex differences in the timing of identification among children and adults with autism spectrum disorder","volume":"43","author":"Begeer","year":"2013","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1088\u2013101","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1023\/a:1005596502855","article-title":"Varieties of repetitive behavior in autism: comparisons to mental retardation","volume":"30","author":"Bodfish","year":"2000","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"99\u2013115","DOI":"10.1002\/mpr.1466","article-title":"Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems","volume":"24","author":"Brugha","year":"2015","journal-title":"International Journal of Methods in Psychiatric Research"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/cap.2010.0121","article-title":"An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders","volume":"21","author":"Buckley","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biopsych.2012.11.022","article-title":"Decreased spontaneous attention to social scenes in 6-month-old infants later diagnosed with ASD","volume":"74","author":"Chawarska","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0033|cit33","volume-title":"Conners Manual","author":"Conners","year":"2008"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0034|cit34","unstructured":"Covidence Veritas Health Innovation 2020"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0035|cit35","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0036|cit36","volume-title":"California Verbal Learning Test - Children\u2019s Version Manual","author":"Delis","year":"1994"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0037|cit37","volume-title":"Delis-Kaplan Executive Function System Technical Manual","author":"Delis","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/7854_2020_136","article-title":"An evolving therapeutic rationale for targeting the \u03b17 nicotinic acetylcholine receptor in autism spectrum disorder","volume":"45","author":"Deutsch","year":"2020","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","article-title":"Global prevalence of autism and other pervasive developmental disorders","volume":"5","author":"Elsabbagh","year":"2012","journal-title":"Autism Research"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","article-title":"Pharmacotherapy for the core symptoms in autistic disorder: current status of the research","volume":"73","author":"Farmer","year":"2013","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008785.pub2","article-title":"Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD)","author":"Fletcher-Watson","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0044|cit44","first-page":"130","article-title":"A scale for rating symptoms of patients with the syndrome of autism in real life settings","volume":"25","author":"Freeman","year":"1986","journal-title":"Journal of the American Academy for Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"224\u201334","DOI":"10.1007\/s12031-019-01351-7","article-title":"Improvement of language in children with autism with combined donepezil and choline treatment","volume":"69","author":"Gabis","year":"2019","journal-title":"Journal of Molecular Neuroscience"},{"issue":"13","key":"10.1002\/14651858.CD013851.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.3390\/ijms21134726","article-title":"Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD)","volume":"21","author":"Genovese","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0047|cit47","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0048|cit48","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"10","key":"10.1002\/14651858.CD013851.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nn1770","article-title":"Time to give up on a single explanation for autism","volume":"9","author":"Happ\u00e9","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1362361312441266","article-title":"Outcomes in adults with autistic spectrum disorder: a historical perspective","volume":"17","author":"Henninger","year":"2013","journal-title":"Autism"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0052|cit52","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2. (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0053|cit53","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0054|cit54","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD013851.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009043.pub3","article-title":"Aripiprazole for autism spectrum disorders (ASD)","author":"Hirsh","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269881117741766","article-title":"Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology","volume":"32","author":"Howes","year":"2018","journal-title":"Journal of Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD013851.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2165\/00003088-200241100-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors","volume":"41","author":"Jann","year":"2002","journal-title":"Clinical Pharmacokinetics"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005040.pub2","article-title":"Risperidone for autism spectrum disorder","author":"Jesner","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/abr.abr_100_18","article-title":"Efficacy of memantine as adjunct therapy for autism spectrum disorder in children aged < 14 years","volume":"7","author":"Karahmadi","year":"2018","journal-title":"Advanced Biomedical Research"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/npp.2013.274","article-title":"Acetylcholine elevations relieves cognitive rigidity and social deficiency in a mouse model of autism","volume":"39","author":"Karvat","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3102\/0034654317740334","article-title":"Social skill interventions for youth and adults with autism spectrum disorder: a systematic review","volume":"88","author":"Ke","year":"2018","journal-title":"Review of Educational Research"},{"issue":"6","key":"10.1002\/14651858.CD013851.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/s1734-1140(12)70927-1","article-title":"Drug therapy in autism: a present and future perspective","volume":"64","author":"Kumar","year":"2012","journal-title":"Pharmacological Reports"},{"issue":"9920","key":"10.1002\/14651858.CD013851.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lombardo","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0064|cit64","volume-title":"Autism Diagnostic Interview-Revised","author":"Le Couteur","year":"2003"},{"issue":"Pt 7","key":"10.1002\/14651858.CD013851.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/brain\/awf160","article-title":"Nicotinic receptor abnormalities in the cerebellar cortex in autism","volume":"125","author":"Lee","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.9758\/cpn.2014.12.1.19","article-title":"Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder","volume":"12","author":"Lee","year":"2014","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0067|cit67","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from: www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0068|cit68","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1192\/bjo.2022.18","article-title":"Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis","volume":"8","author":"Limbu","year":"2022","journal-title":"BJPsych Open"},{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011769","article-title":"Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorders (ASD)","author":"Livingstone","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013851.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","article-title":"What Is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis","volume":"56","author":"Loomes","year":"2017","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0073|cit73","volume-title":"Autism Diagnostic Observational Schedule","author":"Lord","year":"1999"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0074|cit74","volume-title":"ADOS-2: Autism Diagnostic Observation Schedule Manual. Part II: Toddler Module","author":"Lord","year":"2012"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6904a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years\u2014Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016","volume":"69","author":"Maenner","year":"2020","journal-title":"Morbidity and Mortality Weekly Report. Surveillance Summaries"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rasd.2012.11.006","article-title":"Why are there so many unsubstantiated treatments in autism?","volume":"7","author":"Matson","year":"2013","journal-title":"Research in Autism Spectrum Disorder"},{"issue":"12","key":"10.1002\/14651858.CD013851.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1007\/s10803-018-3609-7","article-title":"Brief report: gender and age of diagnosis time trends in children with autism using Australian medicare data","volume":"48","author":"May","year":"2018","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"9","key":"10.1002\/14651858.CD013851.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/DBP.0000000000000097","article-title":"Age at first autism spectrum diagnosis: the role of birth cohort, demographic factors and clinical features","volume":"35","author":"Mazurek","year":"2014","journal-title":"Journal of Developmental Behavioral Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"1041\u201351","DOI":"10.1007\/s10803-017-3282-2","article-title":"Parents suggest which indicators of progress and outcomes should be measured in young children with autism spectrum disorder","volume":"48","author":"McConachie","year":"2018","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0081|cit81","unstructured":"Donepezil HCl & cognitive deficits in autism clinicaltrials.gov\/ct2\/show\/NCT00047697"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0082|cit82","unstructured":"National Institute for Health and Care Excellence (NICE) Autism spectrum disorder in under 19s: support and management. NICE clinical guideline \u2012 CG170; first published August 2013; updated June 2021 www.nice.org.uk\/Guidance\/CG170"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/cap.2006.16.621","article-title":"A prospective, open-label trial of galantamine in autistic disorder","volume":"16","author":"Nicolson","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1586\/14737175.3.4.409","article-title":"Acetylcholinesterase-inhibitors in the treatment of autistic disorders","volume":"3","author":"Niederhofer","year":"2003","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaac.2009.11.009","article-title":"A prospective study of the emergence of early behavioural signs of autism","volume":"49","author":"Ozonoff","year":"2010","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013851.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/19315864.2014.930547","article-title":"Validity study of the CBCL 6\u201318 for the assessment of emotional problems in youth with ASD","volume":"7","author":"Pandolfi","year":"2014","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1176\/appi.ajp.158.7.1058","article-title":"Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain","volume":"158","author":"Perry","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013851.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Applied Psychological Measurement"},{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008511.pub2","article-title":"Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD)","author":"Reichow","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009260.pub3","article-title":"Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)","author":"Reichow","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0091|cit91","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0092|cit92","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2023"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0093|cit93","volume-title":"Behavior Assessment for Children","author":"Reynolds","year":"2015"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1698-3_1580","volume-title":"Encyclopedia of Autism Spectrum Disorders","author":"Ritvo","year":"2013"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fped.2014.00087","article-title":"The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review","volume":"2","author":"Rossignol","year":"2014","journal-title":"Frontiers in Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD013851.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaac.2013.05.019","article-title":"Postsecondary employment experiences among young adults with an autistic spectrum disorder","volume":"52","author":"Roux","year":"2013","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0097|cit97","volume-title":"ADI-R: Autism Diagnostic Interview-Revised","author":"Rutter","year":"2003"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0098|cit98","volume-title":"The Social Communication Questionnaire Manual","author":"Rutter","year":"2003"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0099|cit99","volume-title":"The Childhood Autism Rating Scale","author":"Schopler","year":"1994"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jclinepi.2019.12.020","article-title":"GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy","volume":"122","author":"Sch\u00fcnemann","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0101|cit101","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"417\u201332","DOI":"10.1007\/BF02206868","article-title":"A comparison and evaluation of three commonly used autism scales","volume":"21","author":"Sevin","year":"1991","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13229-022-00488-4","article-title":"Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis","volume":"13","author":"Siafis","year":"2022","journal-title":"Molecular Autism"},{"issue":"5","key":"10.1002\/14651858.CD013851.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00004583-200405000-00008","article-title":"The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders","volume":"43","author":"Skuse","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0105|cit105","first-page":"199","volume-title":"Major Psychological Assessment Instruments","volume":"2","author":"Sparrow","year":"1989"},{"issue":"2","key":"10.1002\/14651858.CD013851.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1037\/\/0021-843x.106.2.280","article-title":"Structure of anxiety symptoms among children: a confirmatory factor-analytic study","volume":"106","author":"Spence","year":"1997","journal-title":"Journal of Abnormal Psychology"},{"issue":"11","key":"10.1002\/14651858.CD013851.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011144.pub2","article-title":"Methylphenidate for children and adolescents with autism spectrum disorder","author":"Sturman","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0108|cit108","unstructured":"Tanner A Dounavi K The emergence of autism symptoms prior to 18 months of age: a systematic literature review Journal of Autism and Developmental Disorders 10.1007\/s10803-020-04618-w 32734422"},{"issue":"7","key":"10.1002\/14651858.CD013851.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/1362361315585643","article-title":"Longitudinal patterns of employment and postsecondary education for adults with autism and average-range IQ","volume":"19","author":"Taylor","year":"2015","journal-title":"Autism"},{"issue":"8","key":"10.1002\/14651858.CD013851.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0111|cit111","volume-title":"Therapies for Children with Autism Spectrum Disorder: Behavioral Interventions Update","author":"Weitlauf","year":"2014"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0112|cit112","unstructured":"World Health Organization (WHO) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research apps.who.int\/iris\/handle\/10665\/37108 1993"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0113|cit113","unstructured":"World Health Organization ICD-11: International Classification of Diseases for Mortality and Morbidity Statistics. Eleventh Revision icd.who.int\/icd11refguide\/en\/index.html"},{"issue":"8","key":"10.1002\/14651858.CD013851.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004677.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013851.pub2-BIB0115|cit115","volume-title":"Diagnostic Interview for Social and Communication Disorders","author":"Wing","year":"2006"},{"issue":"10","key":"10.1002\/14651858.CD013851.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s10803-006-0322-8","article-title":"Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature","volume":"37","author":"Yoo","year":"2007","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1002\/14651858.CD013851.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013851","article-title":"Acetylcholinesterase inhibitors for autistic spectrum disorders","author":"Cox","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T08:27:57Z","timestamp":1719995277000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013851.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":117,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013851.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}